Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Human activity monitoring device
Breathing mask
Signal routing dependent on a loading indicator of a mobile node
Preserving and handling native data in hybrid object trees
Method of operating a split gate flash memory cell with coupling gate
Modification of an object replica
System and method for multi-threaded MIMO OFDM channel equalizer
  Randomly Featured Patents
In-situ method and composition for repairing a thermal barrier coating
Semiconductor device with signal line having decreased characteristic impedance
Anchoring in a construction model
Amplifier feedback and bias configuration
Forming electronic devices
Process for making optical disk substrates
Monitoring system for turbine engine
Method and apparatus for extended control over a wireless medium between two or more devices
Vehicle trunk lid securing apparatus
Piezoelectric crystal firing spring and mount